High-Energy Laser in the Conservative Treatment of Rhizarthrosis
Condition(s) studied
Investigational drug(s) / intervention(s)
THEAL:Ixyon XP (Mectronic, Bergamo, Italy): laser therapy
Study summary
Osteoarthritis (OA) is a degenerative joint disease that can affect the hands and is particularly debilitating when it involves the trapeziometacarpal joint (rhizarthrosis). It causes pain, deformity, limited movement and strength, joint instability, resulting in significant limitations in daily activities.Many conservative treatments, such as medications, therapeutic exercises, physical therapy, and orthoses, are effective for managing hand OA. For patients who do not respond to conservative treatments, surgical intervention will be necessary.
Eligibility
Primary outcome measure(s)
- recovery of pain — change between baseline to 1 month
The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." - recovery of pain — change between baseline to 3 month
The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." - recovery of pain — change between baseline to 6 month
The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Angela Notarnicola | Bari | Italy | Recruiting |
More Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07566507 on ClinicalTrials.gov ↗ ← All trials in Italy